Journal Article

Gene Correction Recovers Phagocytosis in Retinal Pigment Epithelium Derived from Retinitis Pigmentosa-Human-Induced Pluripotent Stem Cells

Clemente, Eleonora, Artero-Castro, Ana, Cortón, Marta, Vidal-Puig, Antonio, Rodriguez-Jimenez, Francisco, Ávila-Fernandez, Almudena, Ayuso, Carmen, Jendelova, Pavla, Long, Kathleen, Bassett, Andrew, Erceg, Slaven

2021

Overview

Hereditary retinal dystrophies (HRD) represent a significant cause of blindness, affecting mostly retinal pigment epithelium (RPE) and photoreceptors (PRs), and currently suffer from a lack of effective treatments. Highly specialized RPE and PR cells interact mutually in the functional retina, therefore primary HRD affecting one cell type leading to a secondary HRD in the other cells. Phagocytosis is one of the primary functions of the RPE and studies have discovered that mutations in the phagocytosis-associated gene Mer tyrosine kinase receptor (MERTK) lead to primary RPE dystrophy. Treatment strategies for this rare disease include the replacement of diseased RPE with healthy autologous RPE to prevent PR degeneration. The generation and directed differentiation of patient-derived human-induced pluripotent stem cells (hiPSCs) may provide a means to generate autologous therapeutically-relevant adult cells, including RPE and PR. However, the continued presence of the MERTK gene mutation in patient-derived hiPSCs represents a significant drawback. Recently, we reported the generation of a hiPSC model of MERTK-associated Retinitis Pigmentosa (RP) that recapitulates disease phenotype and the subsequent creation of gene-corrected RP-hiPSCs using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9. In this study, we differentiated gene-corrected RP-hiPSCs into RPE and found that these cells had recovered both wild-type MERTK protein expression and the lost phagocytosis of fluorescently-labeled photoreceptor outer segments observed in uncorrected RP-hiPSC-RPE. These findings provide proof-of-principle for the utility of gene-corrected hiPSCs as an unlimited cell source for personalized cell therapy of rare vision disorders.

• Publisher: MDPI AG,MDPI
• Subject: c-Mer Tyrosine Kinase - genetics / c-Mer Tyrosine Kinase - metabolism / Cell Differentiation - genetics / Cell Line / CRISPR / Gene Editing / Gene expression / Gene Expression Regulation / Humans / Induced Pluripotent Stem Cells - pathology / Induced Pluripotent Stem Cells - ultrastructure / Kinases / Localization / Morphology / Mutation / Mutation - genetics / Phagocytosis / Protein expression / Proteins / Rare diseases / Retinal Photoreceptor Cell Outer Segment - metabolism / Retinal Photoreceptor Cell Outer Segment - pathology / Retinal Photoreceptor Cell Outer Segment - ultrastructure / Retinal Pigment Epithelium - pathology / Retinal Pigment Epithelium - ultrastructure / Retinitis Pigmentosa - genetics / Retinitis Pigmentosa - pathology / Stem cells